

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | APC ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TAME | ✔ | 98+% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Apcin, a ligand for Cdc20, is a potent, competitive inhibitor of APC/C(Cdc20) Apcin competitively inhibits APC/C-dependent ubiquitination by binding to Cdc20 and preventing substrate recognition. Apcin occupies the D-box binding pocket flanking the WD40 structural domain, which prolongs mitosis[1][2][3].At concentrations of 25-50 μM for 48 hours, Apcin in combination with proTAME (6, 12 μM) significantly increases MM apoptosis[3].At 25 μM concentration, acting for 2-14 hours, Apcin induces slippage at a slower rate[2].In the concentration range of 50-200 μM, Apcin most effectively stabilises cycB1-NT and securin, with a slightly weaker effect on full-length cyclin B1[1].In the concentration range of 1.5-200 μM for 18 hours, Apcin acts synergistically with proTAME, a cell-permeable TAME prodrug, to prolong the mitotic duration of RPE1 cells[1]. |
| Concentration | Treated Time | Description | References | |
| H9C2 cells | 2 μM | 24 h | To assess the potential damage of DOX to cardiomyocytes, observed vacuolization and reduction in cell count. | Cell Mol Biol Lett. 2025 Mar 5;30(1):29. |
| JVM2 cells | 50 μM, 100 μM, 200 μM | 24h, 48h, 72h | Inhibit cell proliferation, migration and invasion, induce cell apoptosis and cell cycle arrest | Exp Hematol Oncol. 2023 Mar 7;12(1):28. |
| Z138 cells | 50 μM, 100 μM, 200 μM | 24h, 48h, 72h | Inhibit cell proliferation, migration and invasion, induce cell apoptosis and cell cycle arrest | Exp Hematol Oncol. 2023 Mar 7;12(1):28. |
| RPE1 cells | 25 μM | 45 h | To evaluate the effects of apcin and proTAME on mitotic duration. Results showed that apcin and proTAME synergistically prolonged mitotic duration. | Nature. 2014 Oct 30;514(7524):646-9. |
| cells in mitotic Xenopus egg extract | 200 μM | 40 min | To evaluate the effects of apcin and its derivatives on the degradation of the N-terminal fragment of cyclin B1. Results showed that apcin effectively inhibited degradation. | Nature. 2014 Oct 30;514(7524):646-9. |
| HCT116 cells | 50 μM | 24 h | To determine the effect of apcin on cyclin B1 degradation, results showed that apcin accelerated cyclin B1 degradation. | Nat Chem Biol. 2020 May;16(5):546-555. |
| hTERT-RPE1 H2B-GFP cells | 0, 3.1, 6.2, 12.5, 25, 50 μM | 24 h | To determine the effect of apcin on mitotic fraction, results showed that apcin dose-dependently decreased the mitotic fraction. | Nat Chem Biol. 2020 May;16(5):546-555. |
| PC3 cells | 50 µM | 48 h | To evaluate the effect of Apcin on PC3 cell viability and apoptosis, results showed that Apcin reduced cell viability and induced apoptosis in a dose-dependent manner | Cancer Lett. 2017 Jan 28;385:207-214. |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6J mice | TRAMP-C2 subcutaneous tumor model | Intraperitoneal injection | 15 mg/kg | Once daily ,4 days per cycle | To evaluate the anti-tumor effect of Apcin combined with anti-PD1 antibodies | Exp Hematol Oncol. 2023 Aug 1;12(1):67 |
| C57BL/6 mice | DOX-induced myocardial injury model | Intraperitoneal injection | 1.5 mg/kg | Once daily for 4 weeks | To evaluate the effect of CDC20 inhibitor Apcin on DOX-induced myocardial injury, found that Apcin exacerbated cardiomyocyte apoptosis. | Cell Mol Biol Lett. 2025 Mar 5;30(1):29. |
| Balb/c nude mice | Z138 cell-driven xenograft tumor model | Intraperitoneal injection | 20 mg/kg | Every other day for 2 weeks | Evaluate the anti-tumor effect and safety of Apcin in vivo | Exp Hematol Oncol. 2023 Mar 7;12(1):28. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.28mL 0.46mL 0.23mL |
11.40mL 2.28mL 1.14mL |
22.80mL 4.56mL 2.28mL |
|
| CAS号 | 300815-04-7 |
| 分子式 | C13H14Cl3N7O4 |
| 分子量 | 438.65 |
| SMILES Code | O=C(OCCN1C([N+]([O-])=O)=CN=C1C)NC(NC2=NC=CC=N2)C(Cl)(Cl)Cl |
| MDL No. | MFCD00525727 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | ZEXHXVOGJFGTRX-UHFFFAOYSA-N |
| Pubchem ID | 2830389 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 120 mg/mL(273.56 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1